logo

For the Inventor, By the Inventor

Monrovia, CA, United States of America

Rajat Varma

LinkedIn

This inventor holds 23 USPTO granted patents and 12 published patent applications, primarily in Heterodimeric Fusion Proteins. Top assignees: Xencor, Inc., Genentech, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajat Varma. Retrieved from https://idiyas.com/inventor/rajat-varma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Monrovia, CA (US) (2019 - 2024)
  • Bethesda, MD (US) (2022 - 2024)
  • Hamden, CT (US) (2022 - 2024)
  • Pasadena, CA (US) (2024)

Company Filing History:

goldMedal23 out of 227 
 
Xencor, Inc.
 patents
silverMedal1 out of 3,298 
 
Genentech, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...
Areas of Expertise:
Heterodimeric Antibodies
CD3 Binding
GPC3
IL-15
IL-15RA
Fc-Fusion Proteins
NKG2D
PD-1
TIM-3
Bispecific Fusion Proteins
Engineered IL-2
Combination Therapies
23 patents (USPTO):Explore Patents
1. 12655230 - HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3 (2026-06-16),
2. 12509495 - LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS (2025-12-30),
3. 12448423 - Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains (2025-10-21),
4. 12239688 - IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof (2025-03-04),
5. 12234270 - IL-12 heterodimeric Fc-fusion proteins (2025-02-25),
6. 12139525 - Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains (2024-11-12),
7. 12006345 - Untargeted and targeted IL-10 Fc-fusion proteins (2024-06-11),
8. 11981717 - Engineered IL-2 Fc fusion proteins (2024-05-14),
9. 11932675 - PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties (2024-03-19),
10. 11859012 - Heterodimeric antibodies that bind CD3 and GPC3 (2024-01-02),
11. 11851466 - Targeted IL-12 heterodimeric Fc-fusion proteins (2023-12-26),
12. 11655277 - IL-12 heterodimeric Fc-fusion proteins (2023-05-23),
13. 11618776 - Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains (2023-04-04),
14. 11584794 - Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments (2023-02-21),
15. 11524991 - PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof (2022-12-13),

Title: The Innovative Journey of Rajat Varma

Introduction: Rajat Varma, a visionary inventor based in Monrovia, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Rajat Varma's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary renewable energy storage system, and a novel cybersecurity solution for IoT devices.

Career Highlights: With over two decades of experience in the tech industry, Rajat Varma has a proven track record of turning innovative ideas into tangible products. He has held key roles in various tech companies, leading research and development teams to success.

Collaborations: Throughout his career, Rajat Varma has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide. His collaborative efforts have resulted in the development of groundbreaking technologies that have shaped the industry.

Conclusion: Rajat Varma's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His dedication to pushing the boundaries of what is possible continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…